Project Details
Description
The purpose of the study is to look at the change in blood sugar levels in people with type 2 diabetes who are using oral semaglutide and planning to fast during Ramadan. Participants will take oral semaglutide as prescribed by the study doctor. The study will last for about 5 months (20 weeks). Participants will be asked to complete a patient diary about how and when they take the oral semaglutide tablets. Participants will complete this diary during the study period as instructed by study doctor.
| Acronym | O-SEMA-Fast |
|---|---|
| Status | Finished |
| Effective start/end date | 25/01/23 → 9/07/23 |
Collaborative partners
- Novo Nordisk Foundation (lead)
- Thumbay hospital Ajman
- Dubai Diabetes Center
- Medcare Hospital
- NMC Hospital
- Oriana Hospital
- Al Garhoud private hospital
- Emirates Health Services
- Dubai Hospital
Keywords
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Glucagon-Like Peptide-1 Receptor Agonists
- Hypoglycemic Agents
- Physiological Effects of Drugs
- Semaglutide
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.